BALTIMORE--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), as previously announced on November 2, 2006, raised $20 million of newly issued convertible debt led by Friedli Corporate Finance, Inc. in Switzerland.
BALTIMORE--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), as previously announced on November 2, 2006, raised $20 million of newly issued convertible debt led by Friedli Corporate Finance, Inc. in Switzerland.
